Show simple item record

dc.contributor.author Nutan, Prakash
dc.contributor.author Patel, Devangi
dc.date.accessioned 2021-08-09T11:43:07Z
dc.date.available 2021-08-09T11:43:07Z
dc.date.issued 2011-01-06
dc.identifier.citation Prakash, N., & Devangi, P. (1948). Drug Discovery. J Antivir Antiretrovir 2: 063-068. doi: 10.4172/jaa. 1000025. OMICS Publishing Group J Antivir Antiretrovir ISSN, 5964, 063-068. en_US
dc.identifier.issn 1948-5964
dc.identifier.uri https://www.longdom.org/abstract/drug-discovery-5704.html
dc.identifier.uri http://10.9.150.37:8080/dspace//handle/atmiyauni/660
dc.description.abstract The drug industry is one of the major players guiding the development of the medicines, biotechnology & pharmacology field. Drug discovery is the process by which drugs are discovered and designed. It is a process which aims at identifying a compound therapeutically useful in curing & treating disease. The process of drug discovery involves the identification of candidates, synthesis, characterization, screening & assays for therapeutic efficacy. Once a compound has shown its value in these tests, it will begin the process of drug development prior to clinical trials. Developing a new drug is a tedious & expensive undertaking, despite promising discoveries and multibillion dollar investments for new drug development is quietly undergoing crisis. Currently, all existing therapies together hit only about 400 different drug targets. It is estimated that there are at least 10 times as many potential drug targets that could be exploited for future drug therapy. en_US
dc.language.iso en_US en_US
dc.publisher Journal of Antivirals & Antiretrovirals en_US
dc.subject Drug discovery; Drug development; Clinical trials; Potential drug targets; Clinical trial en_US
dc.title Drug Discovery en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account